Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: 4-week maximal use trial

被引:0
|
作者
Paller, Amy [1 ]
Hebert, Adelaide A. [2 ,3 ]
Jett, John E. [4 ]
Brown, Philip M. [4 ]
Rubenstein, David S. [4 ]
Piscitelli, Stephen C. [4 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] UTHlth McGovern Med Sch, Houston, TX USA
[3] Childrens Mem Hermann Hosp, Houston, TX USA
[4] Dermavant Sci Inc, Morrisville, NC USA
关键词
D O I
10.1093/bjd/ljac140.005
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
301
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis
    Paller, Amy S.
    Gold, Linda Stein
    Soung, Jennifer
    Tallman, Anna M.
    Rubenstein, David S.
    Gooderham, Melinda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (03) : 632 - 638
  • [22] 671-Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis
    Simpson, Eric
    Silverberg, Jonathan, I
    Bissonnette, Robert
    Gold, Linda Stein
    Armstrong, April W.
    Hebert, Adelaide A.
    Serrao, Rocco T.
    Jakus, Jeannette R.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Tallman, Anna M.
    Eichenfield, Lawrence F.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [23] Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice
    Lubbe, Jann
    Friedlander, Sheila F.
    Cribier, Bernard
    Morren, Marie-Anne
    Garcia-Diez, Amaro
    Gelmetti, Carlo
    Hofmann, Heidelore
    Houwing, Ronald H.
    Kownacki, Stephen
    Langley, Richard G. B.
    Virtanen, Marie
    Wolff, Klaus
    Wisseh, Steve
    McGeown, Claire
    Abrams, Beatrice
    Schneider, Dirk
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2006, 7 (02) : 121 - 131
  • [24] Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for the Treatment of Atopic Dermatitis in Daily Practice
    Lübbe J.
    Friedlander S.F.
    Cribier B.
    Morren M.-A.
    García-Díez A.
    Gelmetti C.
    Hofmann H.
    Houwing R.H.
    Kownacki S.
    Langley R.G.B.
    Virtanen M.
    Wolff K.
    Wisseh S.
    McGeown C.
    Abrams B.
    Schneider D.
    American Journal of Clinical Dermatology, 2006, 7 (2) : 121 - 131
  • [25] Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
    Eichenfield, LF
    Lucky, AW
    Boguniewicz, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (04) : 495 - 504
  • [26] Review of pimecrolimus cream 1% in children for the treatment of mild to moderate atopic dermatitis
    Cohen, Bernard
    CLINICAL PEDIATRICS, 2007, 46 (01) : 7 - 15
  • [27] Pimecrolimus cream 1% once-daily maintenance therapy for the prevention of relapse in mild to moderate atopic dermatitis in adults
    Smith, CH
    Ormerod, AD
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 : 37 - 37
  • [28] Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months
    Friedlander, SF
    Hebert, AA
    Allen, DB
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) : 387 - 393
  • [29] Treatment of children with atopic dermatitis (AD) with 1% SDZ ASM 981 cream (ASM)
    Boguniewicz, M
    Leung, DYM
    Marshall, K
    Bush, C
    Graeber, M
    Cherill, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S308 - S308
  • [30] Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials
    Desai, Seemal R.
    Gold, Linda Stein
    Cameron, Michael C.
    Golant, Alexandra
    Lewitt, G. Michael
    Bruno, Matthew J.
    Martin, George
    Brown, Philip M.
    Rubenstein, David S.
    Butners, Victoria
    Tallman, Anna M.
    DERMATOLOGY AND THERAPY, 2023, 13 (10) : 2443 - 2460